Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Accelerating your down payment savings can make home ownership a reality. Explore ways to enhance your savings efforts.
19,649 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Investors chasing high-tech breakthroughs often bet on early-stage companies like Rigetti. This article breaks down w...
As AI accelerates, two chipmakers stand out for very different reasons. This analysis weighs whether broadcom stock b...
Starting with your first no annual fee card? This guide breaks down the 2023 best no annual fee cards for beginners, ...
Policy headwinds aren’t the end of the story for solar investors. This guide explains how AI-driven demand, select co...
Two early leaders in the electric air taxi race collide with a policy signal that could tilt the field. This analysis...
Two pharma giants sit at the center of the booming weight-loss drug market. This piece breaks down which could offer ...
Quantum computing stocks ionq, Rigetti, and D-Wave have captured investor imaginations with big promises and big vola...
Kalshi is courting a lofty valuation after a recent funding round, signaling confidence in prediction markets amid a ...
CoreCivic has faced a share-price headwind even as revenue climbs. A notable $5 million stake by Hahn Capital signals...
Tuesday brought a notable wobble for the Nasdaq-100, leading the market’s tech retreat. This article breaks down the ...
The IEA just revised demand down by 420,000 barrels per day, signaling slower consumption ahead. This shift could res...